Fixed-dose Drug Combinations of Antibiotics in the Indian Market – A Cause for Concern?
India has the highest number of antibiotic fixed-dose combinations (FDCs) in the market, including inappropriate combinations, which are a major concern for an increased risk of antimicrobial resistance. These FDCs have been licensed for manufacturing without the required prior approval of the central regulator and without proper evidence of rationale, efficacy, and safety. To address […]
Fixed-dose Drug Combinations of Antibiotics in the Indian Market – A Cause for Concern? Read More »

